Skip to main content
. 2011 Jul 12;5(7):e1241. doi: 10.1371/journal.pntd.0001241

Figure 1. Incidence of acute filariasis morbidity during 5-year mass drug administration trial.

Figure 1

Vertical bars around each value are 95% Confidence Intervals (CI). MDA = Mass Drug Administration (combined data from communities given diethylcarbamazine alone or diethylcarbamazine with ivermectin), AFM = acute filariasis morbidity, person-years of observation = pyo.